| Product Code: ETC9940391 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Celiac Drugs Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Celiac Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Celiac Drugs Market - Industry Life Cycle |
3.4 United Kingdom (UK) Celiac Drugs Market - Porter's Five Forces |
3.5 United Kingdom (UK) Celiac Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United Kingdom (UK) Celiac Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 United Kingdom (UK) Celiac Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 United Kingdom (UK) Celiac Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 United Kingdom (UK) Celiac Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Kingdom (UK) Celiac Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of celiac disease in the UK |
4.2.2 Growing awareness about celiac disease and the availability of treatment options |
4.2.3 Technological advancements in drug development for celiac disease |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in the UK |
4.3.2 Limited reimbursement policies for celiac drugs |
4.3.3 Competition from alternative treatments like gluten-free diets |
5 United Kingdom (UK) Celiac Drugs Market Trends |
6 United Kingdom (UK) Celiac Drugs Market, By Types |
6.1 United Kingdom (UK) Celiac Drugs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Celiac Drugs Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Celiac Drugs Market Revenues & Volume, By Biological Drugs, 2021- 2031F |
6.1.4 United Kingdom (UK) Celiac Drugs Market Revenues & Volume, By Immunosuppresants, 2021- 2031F |
6.1.5 United Kingdom (UK) Celiac Drugs Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.1.6 United Kingdom (UK) Celiac Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Kingdom (UK) Celiac Drugs Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Celiac Drugs Market Revenues & Volume, By Classical Celiac Disease, 2021- 2031F |
6.2.3 United Kingdom (UK) Celiac Drugs Market Revenues & Volume, By Non- Classical Celiac Disease, 2021- 2031F |
6.2.4 United Kingdom (UK) Celiac Drugs Market Revenues & Volume, By Silent Celiac Disease, 2021- 2031F |
6.3 United Kingdom (UK) Celiac Drugs Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Celiac Drugs Market Revenues & Volume, By Topical, 2021- 2031F |
6.3.3 United Kingdom (UK) Celiac Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 United Kingdom (UK) Celiac Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.5 United Kingdom (UK) Celiac Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United Kingdom (UK) Celiac Drugs Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Celiac Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United Kingdom (UK) Celiac Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 United Kingdom (UK) Celiac Drugs Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.4.5 United Kingdom (UK) Celiac Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United Kingdom (UK) Celiac Drugs Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Celiac Drugs Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.5.3 United Kingdom (UK) Celiac Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.4 United Kingdom (UK) Celiac Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.5 United Kingdom (UK) Celiac Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.6 United Kingdom (UK) Celiac Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) Celiac Drugs Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Celiac Drugs Market Export to Major Countries |
7.2 United Kingdom (UK) Celiac Drugs Market Imports from Major Countries |
8 United Kingdom (UK) Celiac Drugs Market Key Performance Indicators |
8.1 Patient adherence rate to celiac drug therapy |
8.2 Number of clinical trials for new celiac drugs in the UK |
8.3 Rate of prescription of celiac drugs by healthcare providers |
9 United Kingdom (UK) Celiac Drugs Market - Opportunity Assessment |
9.1 United Kingdom (UK) Celiac Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United Kingdom (UK) Celiac Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 United Kingdom (UK) Celiac Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 United Kingdom (UK) Celiac Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 United Kingdom (UK) Celiac Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Kingdom (UK) Celiac Drugs Market - Competitive Landscape |
10.1 United Kingdom (UK) Celiac Drugs Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Celiac Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here